Hamm S - Search Results

1

A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice.

Wiedemann GM, Jacobi SJ, Chaloupka M, Krächan A, Hamm S, Strobl S, Baumgartner R, Rothenfusser S, Duewell P, Endres S, Kobold S. Wiedemann GM, et al. Among authors: hamm s. Oncoimmunology. 2016 May 31;5(7):e1189051. doi: 10.1080/2162402X.2016.1189051. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622045 Free PMC article.

2

Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.

Hamm S, Rath S, Michel S, Baumgartner R. Hamm S, et al. J Immunotoxicol. 2009 Dec;6(4):257-65. doi: 10.3109/15476910903286733. J Immunotoxicol. 2009. PMID: 19848448 Free article.

3

A novel microtubule inhibitor 4SC-207 with anti-proliferative activity in taxane-resistant cells.

Bausch E, Kohlhof H, Hamm S, Krauss R, Baumgartner R, Sironi L. Bausch E, et al. Among authors: hamm s. PLoS One. 2013 Nov 6;8(11):e79594. doi: 10.1371/journal.pone.0079594. eCollection 2013. PLoS One. 2013. PMID: 24324550 Free PMC article.

4

Alternating 2'-O-ribose methylation is a universal approach for generating non-stimulatory siRNA by acting as TLR7 antagonist.

Hamm S, Latz E, Hangel D, Müller T, Yu P, Golenbock D, Sparwasser T, Wagner H, Bauer S. Hamm S, et al. Immunobiology. 2010 Jul;215(7):559-69. doi: 10.1016/j.imbio.2009.09.003. Epub 2009 Oct 25. Immunobiology. 2010. PMID: 19854535

5

DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.

Gruber W, Hutzinger M, Elmer DP, Parigger T, Sternberg C, Cegielkowski L, Zaja M, Leban J, Michel S, Hamm S, Vitt D, Aberger F. Gruber W, et al. Among authors: hamm s. Oncotarget. 2016 Feb 9;7(6):7134-48. doi: 10.18632/oncotarget.6910. Oncotarget. 2016. PMID: 26784250 Free PMC article.

6

Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog-GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition.

Peer E, Aichberger SK, Vilotic F, Gruber W, Parigger T, Grund-Gröschke S, Elmer DP, Rathje F, Ramspacher A, Zaja M, Michel S, Hamm S, Aberger F. Peer E, et al. Among authors: hamm s. Cancers (Basel). 2021 Aug 23;13(16):4227. doi: 10.3390/cancers13164227. Cancers (Basel). 2021. PMID: 34439381 Free PMC article.

7

Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME).

Bretz AC, Parnitzke U, Kronthaler K, Dreker T, Bartz R, Hermann F, Ammendola A, Wulff T, Hamm S. Bretz AC, et al. Among authors: hamm s. J Immunother Cancer. 2019 Nov 8;7(1):294. doi: 10.1186/s40425-019-0745-3. J Immunother Cancer. 2019. PMID: 31703604 Free PMC article.

8

Pattern recognition by Toll-like receptors.

Bauer S, Müller T, Hamm S. Bauer S, et al. Among authors: hamm s. Adv Exp Med Biol. 2009;653:15-34. doi: 10.1007/978-1-4419-0901-5_2. Adv Exp Med Biol. 2009. PMID: 19799109 Review.

9

Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo.

Hamm S, Heit A, Koffler M, Huster KM, Akira S, Busch DH, Wagner H, Bauer S. Hamm S, et al. Int Immunol. 2007 Mar;19(3):297-304. doi: 10.1093/intimm/dxl146. Epub 2007 Feb 7. Int Immunol. 2007. PMID: 17289655

10

Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9.

Bauer S, Pigisch S, Hangel D, Kaufmann A, Hamm S. Bauer S, et al. Among authors: hamm s. Immunobiology. 2008;213(3-4):315-28. doi: 10.1016/j.imbio.2007.10.010. Epub 2007 Nov 28. Immunobiology. 2008. PMID: 18406377 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters